Nexalis Therapeutics Limited (ASX:NX1)
0.0230
+0.0040 (21.05%)
At close: Apr 17, 2026
27.78% (1Y)
| Market Cap | 5.82M -19.3% |
| Revenue (ttm) | 986.43K +145.5% |
| Net Income | -1.62M |
| EPS | -0.01 |
| Shares Out | 253.04M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 34,079 |
| Average Volume | 110,057 |
| Open | 0.0200 |
| Previous Close | 0.0190 |
| Day's Range | 0.0200 - 0.0230 |
| 52-Week Range | 0.0170 - 0.0480 |
| Beta | 0.06 |
| RSI | 51.86 |
| Earnings Date | May 22, 2026 |